Berlin - Delayed Quote • EUR
G1 Therapeutics Inc (G1H.BE)
At close: April 26 at 8:30 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-56,177.0000
-38,337.0000
-128,620.0000
-132,108.0000
-83,742.0000
Investing Cash Flow
-9,905.0000
2,810.0000
-50,529.0000
--
152.0000
Financing Cash Flow
25,404.0000
-26,912.0000
52,495.0000
145,863.0000
21,688.0000
End Cash Position
52,873.0000
32,468.0000
94,907.0000
221,561.0000
207,806.0000
Interest Paid Supplemental Data
9,333.0000
8,807.0000
7,924.0000
2,908.0000
997.0000
Capital Expenditure
--
--
-506.0000
--
--
Issuance of Capital Stock
--
--
52,383.0000
86,429.0000
--
Issuance of Debt
--
--
--
55,000.0000
20,000.0000
Repayment of Debt
--
-26,688.0000
--
--
--
Free Cash Flow
-56,177.0000
-38,337.0000
-129,126.0000
-132,108.0000
-83,742.0000
12/31/2020 - 5/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade